[Remote] Medical Science Liaison at Acadia Pharmaceuticals

United States

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Advanced science or clinical degree (e.g. MD, DO, Pharm.D., PhD, NP, PA)
5+ years field Medical Science Liaison experience
Rare disease experience or prior experience in hepatology and/or gastroenterology
Ability to understand and effectively communicate scientific information
Strong oral, written, and communication skills
Ability to travel frequently, up to 60% overnight travel
Valid drivers’ license
Advanced computer skills (MS Office, Word, Excel, PowerPoint)
Excellent organizational skills
Strong business acumen
Launch experience preferred

Responsibilities

Identify, gain access to, and develop professional relationships with thought leaders and other healthcare professionals, active and potential study investigators, and professional organizations within their assigned geography
Support research initiatives across development and provide support to clinical site investigators
Serve as a liaison between HCPs who express interest in conducting investigator-initiated research to facilitate review and consideration of research proposals
Engage in scientific exchange in response to HCP requests
Articulate relevant scientific and clinical information relative to the therapeutic area to HCPs and researchers
Deliver impactful presentations to varying audiences and in a variety of different settings
Provide accurate and unbiased assessment of community needs to senior management
Support company-sponsored research, investigator-initiated research, and publications
Support planning and execution of advisory boards
Stay abreast of emerging scientific literature and clinical data
Support the congress and conference strategy, providing scientific support and communication of scientific insights
Comply with all company SOPs, regulatory requirements, and applicable laws
Complete other responsibilities in a timely manner, as assigned

Skills

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free